Gene Analysis in Studying Susceptibility to Wilms Tumor

Plain-language summary

This study examined samples using laboratory biomarker analysis to understand genetic factors that may contribute to susceptibility to Wilms tumor. It included blood samples from specific control groups. The study was carried out as a non-phase study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

Children's Oncology Group

Intervention

Laboratory Biomarker Analysis

Start date

10/1/2009

Estimated completion

11/1/2009

Countries

United States

Related genes

Locations

• Philadelphia, United States

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* 3000 samples from the 1958 Birth Cohort (58C) and 3000 from the UK Blood Service control series (NBS)